Ebselen attenuates tobramycin-induced ototoxicity in mice
- 5 March 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (2), 271-277
- https://doi.org/10.1016/j.jcf.2020.02.014
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- New developments in aminoglycoside therapy and ototoxicityHearing Research, 2011
- Mechanisms of Aminoglycoside Ototoxicity and Targets of Hair Cell ProtectionInternational Journal of Otolaryngology, 2011
- Protective effect of edaravone against tobramycin-induced ototoxicityActa Oto-Laryngologica, 2009
- Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic culturesHearing Research, 2008
- Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-upBMC Ear, Nose and Throat Disorders, 2007
- Compounds for the prevention and treatment of noise-induced hearing lossDrug Discovery Today, 2005
- Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselenHearing Research, 2005
- Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugsJournal of Pineal Research, 2000
- Application of Antioxidants and Other Agents to Prevent Cisplatin OtotoxicityThe Laryngoscope, 1999
- A mouse model for the delta F508 allele of cystic fibrosis.JCI Insight, 1995